Ask AI

Advanced Practice Providers’ Cardio Intensive 2025: ASCVD Prevention Through Individualized Pharmacologic and Supportive Care Management of Hyperlipidemia

For advanced practice providers, learn how to develop individualized, guideline-concordant treatment plans for patients with hyperlipidemia using nonstatin or combination therapies to facilitate atherosclerotic cardiovascular disease prevention, through an expert-written ClinicalThought, downloadable slides, and on-demand webcasts.

Share

Program Content

Activities

Numbers to Nuance in Hyperlipidemia
From Numbers to Nuance in Hyperlipidemia: Expert Insights on Frequently Asked Questions About ASCVD Prevention and Lipid Management
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 30, 2025

Activities

Hyperlipidemia 2025 cardio intensive
ASCVD Prevention Through Individualized Pharmacologic and Supportive Care Management of Hyperlipidemia
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2025

Activities

2025 Cardio Intensive Hyperlipidemia 1
Comprehensive Hyperlipidemia Care: ASCVD Pathophysiology and the Importance of Achieving Lipid Targets
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 26, 2025

Expires: December 25, 2026

2025 Cardio Intensive Hyperlipidemia 2
Comprehensive Hyperlipidemia Care: Personalizing Lipid-Lowering ​Treatment Beyond Statin Therapy
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 23, 2025

Expires: December 22, 2026

2025 Cardio Intensive Hyperlipidemia 3
Comprehensive Hyperlipidemia Care: Role of Lipoprotein(a) in ASCVD and ​Investigational Lipid-Lowering Agents
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 26, 2025

Expires: December 25, 2026

Provided by

ProCE Banner

Provided by Practicing Clinicians Exchange, LLC in partnership with the Academy of Physician Associates in Cardiology (APAC).

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Partners

Academy of Physician Associates in Cardiology (APAC)

ProCE Banner